Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard R Chaitman

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Circulation|May 8, 2015
Is the 99th Percentile the Optimal Reference Limit to Diagnose Myocardial Infarction With High-Sensitivity Cardiac Troponin Assays in Patients With Chronic Kidney Disease?Bernard R Chaitman
The Canadian Journal of Cardiology|October 20, 2005
Pharmacological approaches to the symptomatic treatment of chronic stable angina: a historical perspective and future directionsBernard R Chaitman
Circulation|January 31, 2007
Should early acceleration of heart rate during exercise be used to risk stratify patients with suspected or established coronary artery disease?Bernard R Chaitman
Circulation|November 28, 2007
An electrocardiogram should not be included in routine preparticipation screening of young athletesBernard R Chaitman
Nature Clinical Practice. Cardiovascular Medicine|October 26, 2006
When should ranolazine be considered for the treatment of chronic angina?Bernard R Chaitman
Journal of the American College of Cardiology|September 6, 2003
Abnormal heart rate responses to exercise predict increased long-term mortality regardless of coronary disease extent: the question is why?Bernard R Chaitman
Journal of Cardiovascular Pharmacology and Therapeutics|September 21, 2004
Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trialsBernard R Chaitman
Circulation|May 24, 2006
Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditionsBernard R Chaitman
European Heart Journal|December 28, 2017
Exaggerated exercise-induced sytolic blood pressure response: arterial baroreceptor sensitivity or carotid stiffness?Bernard R Chaitman
Current Problems in Cardiology|December 26, 2002
Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitorBernard R Chaitman
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Circulation|May 8, 2015
Is the 99th Percentile the Optimal Reference Limit to Diagnose Myocardial Infarction With High-Sensitivity Cardiac Troponin Assays in Patients With Chronic Kidney Disease?Bernard R Chaitman
The Canadian Journal of Cardiology|October 20, 2005
Pharmacological approaches to the symptomatic treatment of chronic stable angina: a historical perspective and future directionsBernard R Chaitman
Circulation|January 31, 2007
Should early acceleration of heart rate during exercise be used to risk stratify patients with suspected or established coronary artery disease?Bernard R Chaitman
Circulation|November 28, 2007
An electrocardiogram should not be included in routine preparticipation screening of young athletesBernard R Chaitman
Nature Clinical Practice. Cardiovascular Medicine|October 26, 2006
When should ranolazine be considered for the treatment of chronic angina?Bernard R Chaitman
Journal of the American College of Cardiology|September 6, 2003
Abnormal heart rate responses to exercise predict increased long-term mortality regardless of coronary disease extent: the question is why?Bernard R Chaitman
Journal of Cardiovascular Pharmacology and Therapeutics|September 21, 2004
Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trialsBernard R Chaitman
Circulation|May 24, 2006
Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditionsBernard R Chaitman
European Heart Journal|December 28, 2017
Exaggerated exercise-induced sytolic blood pressure response: arterial baroreceptor sensitivity or carotid stiffness?Bernard R Chaitman
Current Problems in Cardiology|December 26, 2002
Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitorBernard R Chaitman
Pageof 17